AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
CAS Number
909561-15-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BNCB2059-500 500 µL
Anti-TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), Biotin conjugate
Ask
View Details 
MBS6187928-01 0.1 mL
PIK3R6 (Phosphoinositide-3-Kinase, Regulatory Subunit 6, C17orf38, DKFZp666P158, FLJ34500, HsT41028, p84, p87(PIKAP), p87PIKAP) (PE)
Ask
View Details 
MBS6187928-02 5x 0.1 mL
PIK3R6 (Phosphoinositide-3-Kinase, Regulatory Subunit 6, C17orf38, DKFZp666P158, FLJ34500, HsT41028, p84, p87(PIKAP), p87PIKAP) (PE)
Ask
View Details 
MBS1030688-01 0.02 mg (E-Coli)
Recombinant Anaerocellum thermophilum Shikimate kinase (aroK)
Ask
View Details MBS1030688-02 0.1 mg (E-Coli)
Recombinant Anaerocellum thermophilum Shikimate kinase (aroK)
Ask
View Details